...
首页> 外文期刊>Stem Cell Reports >The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
【24h】

The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential

机译:p53亚型Δ133p53β增强癌症干细胞潜能

获取原文
           

摘要

Cancer stem cells (CSC) are responsible for cancer chemoresistance and metastasis formation. Here we report that D133p53b, a TP53splice variant, enhanced cancer cell stemness in MCF-7 breast cancer cells, while its depletion reduced it. D133p53b stimulated theexpression of the key pluripotency factors SOX2, OCT3/4, and NANOG. Similarly, in highly metastatic breast cancer cells, aggressivenesswas coupled with enhanced CSC potential and D133p53b expression. Like in MCF-7 cells, SOX2, OCT3/4, and NANOG expression werepositively regulated by D133p53b in these cells. Finally, treatment of MCF-7 cells with etoposide, a cytotoxic anti-cancer drug, increasedCSC formation and SOX2, OCT3/4, and NANOG expression via D133p53, thus potentially increasing the risk of cancer recurrence. Ourfindings show that D133p53b supports CSC potential. Moreover, they indicate that the TP53 gene, which is considered a major tumorsuppressor gene, also acts as an oncogene via the D133p53b isoform.
机译:癌症干细胞(CSC)负责癌症的化学抗性和转移形成。在这里,我们报道TP53剪接变体D133p53b增强了MCF-7乳腺癌细胞的癌细胞干性,而其消耗减少了它。 D133p53b刺激了关键多能性因子SOX2,OCT3 / 4和NANOG的表达。同样,在高度转移性乳腺癌细胞中,侵袭性与增强的CSC潜能和D133p53b表达结合。像在MCF-7细胞中一样,SOX2,OCT3 / 4和NANOG表达在这些细胞中受到D133p53b的正调控。最后,用依托泊苷(一种具有细胞毒性的抗癌药)治疗MCF-7细胞,可通过D133p53增加CSC的形成以及SOX2,OCT3 / 4和NANOG的表达,从而有可能增加癌症复发的风险。我们的发现表明D133p53b支持CSC潜力。此外,它们表明,被认为是主要的抑癌基因的TP53基因也通过D133p53b亚型作为癌基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号